Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2015

Open Access 01-12-2015 | Research article

Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study

Authors: Javier Fernández-Torres, Cristina Hernández-Díaz, Rolando Espinosa-Morales, Javier Camacho-Galindo, Norma del Carmen Galindo-Sevilla, Ámbar López-Macay, Yessica Zamudio-Cuevas, Karina Martínez-Flores, Mónica Guadalupe Santamaría-Olmedo, Carlos Pineda, Julio Granados, Gabriela Angélica Martínez-Nava, Marwin Gutiérrez, Alberto G. López-Reyes

Published in: BMC Musculoskeletal Disorders | Issue 1/2015

Login to get access

Abstract

Background

Osteoarthritis (OA) is a multifactorial degenerative condition of the whole joint with a complex pathogenesis whose development and progression is significantly mediated by interactions between the joint cartilage and articular tissues, particularly, proinflammatory mediators and oxidative stress, which results in cartilage deterioration and subchondral bone destruction. HIF-1 alpha regulates oxygen homeostasis in hypoxic tissues such as joint cartilage; efficiency of transcriptional activity of the HIF1A gene is strongly influenced by the presence of polymorphic variants. Given the loss of articular cartilage and with intention to restore damaged tissue, WISP-1 participates in the development of subchondral bone; further, its expression is highly increased in chondrocytes of OA patients. The aim of this study was to evaluate gene frequencies of HIF1A and WISP1 polymorphisms in Mexican patients suffering from knee OA.

Methods

We determined HIF1A rs11549465 (P582S), rs11549467 (A588T), and rs2057482 (C191T), and WISP1 rs2929970 (A2364G) polymorphisms in 70 Mexican patients with knee OA and compare them to those present in 66 ethnically matched healthy controls. Genotyping for these polymorphisms was performed by Real-Time PCR using TaqMan probes.

Results

Gene frequencies exhibited a significant increase of the CC genotype of rs11549465 polymorphism in knee OA patients as compared with those present in controls (P = 0.003 OR = 5.7, 95 % CI = 1.7–21.6); CT genotype and T allele showed decreased frequency in the knee OA group vs. the controls (P = 0.003 OR = 0.2, CI = 0.05–0.6; and P = 0.004 OR = 0.2, CI = 0.05–0.65, respectively). Allele frequencies of the other polymorphic variants were similar in both patients and controls.

Conclusions

These results suggest that the presence of the rs11549465 SNP (HIF1A) plays a role protective in the loss of articular cartilage in our population, and offers the possibility to further study the molecular mechanisms within cartilage and subchondral bone.
Appendix
Available only for authorised users
Literature
1.
go back to reference Meulenbelt I. Osteoarthritis year 2011 in review: genetics. Osteoarthritis Cartilage. 2012;20:218–22.CrossRefPubMed Meulenbelt I. Osteoarthritis year 2011 in review: genetics. Osteoarthritis Cartilage. 2012;20:218–22.CrossRefPubMed
2.
go back to reference Fernández M, Rego F, Blanco F. Genetics in osteoarthritis. Reumatol Clin. 2007;3 Suppl 3:S1 3-8. Fernández M, Rego F, Blanco F. Genetics in osteoarthritis. Reumatol Clin. 2007;3 Suppl 3:S1 3-8.
4.
go back to reference Tawonsawatruk T, Changthong T, Pingsuthiwong S, Trachoo O, Saura T, Wajanavisit W. A genetic association study between growth differentiation factor (GDF5) polymorphism and knee osteoarthritis in Thai population. J Orthopaed Surg Res. 2011;6:2–5.CrossRef Tawonsawatruk T, Changthong T, Pingsuthiwong S, Trachoo O, Saura T, Wajanavisit W. A genetic association study between growth differentiation factor (GDF5) polymorphism and knee osteoarthritis in Thai population. J Orthopaed Surg Res. 2011;6:2–5.CrossRef
5.
go back to reference Shin M, Lee S, Kee S, Song S, Kweon S, Park D, et al. Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis. Joint Bone Spine. 2012;79:488–91.CrossRefPubMed Shin M, Lee S, Kee S, Song S, Kweon S, Park D, et al. Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis. Joint Bone Spine. 2012;79:488–91.CrossRefPubMed
6.
go back to reference Shi D, Zheng Q, Chen D, Zhu L, Qin A, Fan J, et al. Association of single-nucleotide polymorphism in HLA class II/III region with knee osteoarthritis. Osteoarthritis Cartilage. 2010;18:1454–7.CrossRefPubMed Shi D, Zheng Q, Chen D, Zhu L, Qin A, Fan J, et al. Association of single-nucleotide polymorphism in HLA class II/III region with knee osteoarthritis. Osteoarthritis Cartilage. 2010;18:1454–7.CrossRefPubMed
7.
go back to reference Meulenbelt I, Min J, Bos S, Riyazi N, Houwing J, Wijk H, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet. 2008;17:1867–75.CrossRefPubMed Meulenbelt I, Min J, Bos S, Riyazi N, Houwing J, Wijk H, et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet. 2008;17:1867–75.CrossRefPubMed
8.
9.
go back to reference De Filippis L, Gulli S, Caliri A, Romano C, Munaó F, Trimarchi G, et al. Epidemiology and risk factors in osteoarthritis: literature review data from “OASIS” study. Reumatismo. 2004;56:169–84.PubMed De Filippis L, Gulli S, Caliri A, Romano C, Munaó F, Trimarchi G, et al. Epidemiology and risk factors in osteoarthritis: literature review data from “OASIS” study. Reumatismo. 2004;56:169–84.PubMed
10.
go back to reference Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R, Garza-Elizondo M, et al. Epidemiology of the Rheumatic Disease in Mexico. A Study of 5 regions based on the COPCORD Methodology. J Rheum Suppl. 2011;86:3–8.CrossRef Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R, Garza-Elizondo M, et al. Epidemiology of the Rheumatic Disease in Mexico. A Study of 5 regions based on the COPCORD Methodology. J Rheum Suppl. 2011;86:3–8.CrossRef
11.
12.
go back to reference Ströbel S, Loparic M, Wendt D, Schenk A, Candrian C, Lindberg R, et al. Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis Res Ther. 2010;12:R34.CrossRefPubMedPubMedCentral Ströbel S, Loparic M, Wendt D, Schenk A, Candrian C, Lindberg R, et al. Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis Res Ther. 2010;12:R34.CrossRefPubMedPubMedCentral
13.
go back to reference Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 2001;15:2865–76.PubMedPubMedCentral Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 2001;15:2865–76.PubMedPubMedCentral
14.
go back to reference Gelse K, Pfander D, Obier S, Knaup KX, Wiesener M, Henning FF, et al. Role of hypoxia-inducible factor 1 alpha in the integrity of articular cartilage in murine knee joints. Arthritis Res Ther. 2008;10(5):R111.CrossRefPubMedPubMedCentral Gelse K, Pfander D, Obier S, Knaup KX, Wiesener M, Henning FF, et al. Role of hypoxia-inducible factor 1 alpha in the integrity of articular cartilage in murine knee joints. Arthritis Res Ther. 2008;10(5):R111.CrossRefPubMedPubMedCentral
15.
go back to reference Grimmer C, Pfander D, Swoboda B, Aingner T, Mueller L, Henning F, et al. Hypoxia-inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes. Arthritis Rheum. 2007;56:4084–94.CrossRefPubMed Grimmer C, Pfander D, Swoboda B, Aingner T, Mueller L, Henning F, et al. Hypoxia-inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes. Arthritis Rheum. 2007;56:4084–94.CrossRefPubMed
16.
go back to reference Pfander D, Swoboda B, Cramer T. The role of HIF-1 alpha in maintaining cartilage homeostasis and during the pathogenesis of osteoarthritis. Arthritis Res Ther. 2006;8:104. Epub 2006 Jan 18.CrossRefPubMedPubMedCentral Pfander D, Swoboda B, Cramer T. The role of HIF-1 alpha in maintaining cartilage homeostasis and during the pathogenesis of osteoarthritis. Arthritis Res Ther. 2006;8:104. Epub 2006 Jan 18.CrossRefPubMedPubMedCentral
17.
go back to reference Görlach A. Regulation of HIF-1 alpha at the transcriptional level. Curr Pharm Des. 2009;15:3844–52.CrossRefPubMed Görlach A. Regulation of HIF-1 alpha at the transcriptional level. Curr Pharm Des. 2009;15:3844–52.CrossRefPubMed
18.
go back to reference Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000;88:1474–80.PubMed Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000;88:1474–80.PubMed
19.
20.
go back to reference Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1 alpha protein stability and function. Diabetes. 2004;53:3226–32.CrossRefPubMed Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1 alpha protein stability and function. Diabetes. 2004;53:3226–32.CrossRefPubMed
21.
go back to reference Zhou J, Hara K, Inoue M, Hamada S, Yasuda H, Moriyama H, et al. Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions. Kobe J Med Sci. 2008;53:283–96.PubMed Zhou J, Hara K, Inoue M, Hamada S, Yasuda H, Moriyama H, et al. Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions. Kobe J Med Sci. 2008;53:283–96.PubMed
22.
go back to reference Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, et al. Hypoxia-inducible factor-1a polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis. 2003;24:1779–83.CrossRefPubMed Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, et al. Hypoxia-inducible factor-1a polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis. 2003;24:1779–83.CrossRefPubMed
23.
go back to reference Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N, Kishi S, et al. Genetic variation in the hypoxia-inducible factor-1α gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab. 2005;90:5841–7.CrossRefPubMed Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N, Kishi S, et al. Genetic variation in the hypoxia-inducible factor-1α gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab. 2005;90:5841–7.CrossRefPubMed
24.
go back to reference Tzouvelekis A, Ntolios P, Karameris A, Koutsopoulos A, Boglou P, Koulelidis A, et al. Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes. 2012;5:654. doi:10.1186/1756-0500-5-654.CrossRefPubMedPubMedCentral Tzouvelekis A, Ntolios P, Karameris A, Koutsopoulos A, Boglou P, Koulelidis A, et al. Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes. 2012;5:654. doi:10.​1186/​1756-0500-5-654.CrossRefPubMedPubMedCentral
25.
go back to reference Sartori-Cintra AR, Mara CS, Argolo DL, Coimbra IB. Regulation of hypoxia-inducible factor-1α (HIF-1α) expression by interleukin-1β (IL-1 β), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes. Clinics (Säo Paulo, Brazil). 2012;67:35–40.CrossRef Sartori-Cintra AR, Mara CS, Argolo DL, Coimbra IB. Regulation of hypoxia-inducible factor-1α (HIF-1α) expression by interleukin-1β (IL-1 β), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes. Clinics (Säo Paulo, Brazil). 2012;67:35–40.CrossRef
26.
go back to reference Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C, Varol A, et al. Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer. Exp Biol Med. 2009;234:1109–16.CrossRef Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C, Varol A, et al. Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer. Exp Biol Med. 2009;234:1109–16.CrossRef
27.
go back to reference Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW, et al. Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl. 2012;14:864–9.CrossRefPubMedPubMedCentral Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW, et al. Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl. 2012;14:864–9.CrossRefPubMedPubMedCentral
28.
go back to reference Alidoosti M, Ghaedi M, Soleimani A, Bakhtiyari S, Rezvanfard M, Golkhu S, et al. Study on the role of environmental parameters and HIF-1A gene polymorphism in coronary collateral formation among patients with ischemic heart disease. Clin Biochem. 2010;44:1421–4.CrossRef Alidoosti M, Ghaedi M, Soleimani A, Bakhtiyari S, Rezvanfard M, Golkhu S, et al. Study on the role of environmental parameters and HIF-1A gene polymorphism in coronary collateral formation among patients with ischemic heart disease. Clin Biochem. 2010;44:1421–4.CrossRef
29.
go back to reference Bahadori B, Uitz E, Mayer A, Harauer J, Dam K, Truschnig-Wilders M, et al. Polymorphisms of the hypoxia-inducible factor 1 gene and peripheral artery disease. Vasc Med. 2010;15:371–4.CrossRefPubMed Bahadori B, Uitz E, Mayer A, Harauer J, Dam K, Truschnig-Wilders M, et al. Polymorphisms of the hypoxia-inducible factor 1 gene and peripheral artery disease. Vasc Med. 2010;15:371–4.CrossRefPubMed
31.
go back to reference Kolyada AY, Tighiouart H, Perianayagam MC, Liangos O, Madias NE, Jaber BL. A genetic variant of hypoxia-inducible factor-1 alpha is associated with adverse outcomes in acute kidney injury. Kidney Int. 2009;75:1322–9.CrossRefPubMedPubMedCentral Kolyada AY, Tighiouart H, Perianayagam MC, Liangos O, Madias NE, Jaber BL. A genetic variant of hypoxia-inducible factor-1 alpha is associated with adverse outcomes in acute kidney injury. Kidney Int. 2009;75:1322–9.CrossRefPubMedPubMedCentral
32.
go back to reference Sánchez EN, Nava S, Morán C, Romero JF, Cerbón MA. The two leading hypothesis regarding the molecular mechanisms and etiology of preeclampsia, and the Mexican experience in the world context. Rev Invest Clin. 2010;62:252–60. Sánchez EN, Nava S, Morán C, Romero JF, Cerbón MA. The two leading hypothesis regarding the molecular mechanisms and etiology of preeclampsia, and the Mexican experience in the world context. Rev Invest Clin. 2010;62:252–60.
33.
go back to reference Nava S, Sánchez E, Mendoza CA, Morán C, Romero JF, Cerbón MA. Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: a case-control study. BMC Res Notes. 2011;4:68.CrossRef Nava S, Sánchez E, Mendoza CA, Morán C, Romero JF, Cerbón MA. Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: a case-control study. BMC Res Notes. 2011;4:68.CrossRef
34.
go back to reference Schett G, Zwerina J, David JP. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol. 2008;4:473–80.CrossRefPubMed Schett G, Zwerina J, David JP. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol. 2008;4:473–80.CrossRefPubMed
35.
go back to reference Blom A, Brockbank S, Lent P, Beuningen H, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis. Arthritis Rheum. 2009;60:501–12.CrossRefPubMed Blom A, Brockbank S, Lent P, Beuningen H, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis. Arthritis Rheum. 2009;60:501–12.CrossRefPubMed
36.
go back to reference Ono M, Inkson C, Kilts T, Young M. WISP-1/CCN4 Regulates by enhancing BMP-2 activity. J Bone Miner Res. 2011;26:193–208.CrossRefPubMed Ono M, Inkson C, Kilts T, Young M. WISP-1/CCN4 Regulates by enhancing BMP-2 activity. J Bone Miner Res. 2011;26:193–208.CrossRefPubMed
37.
go back to reference Leask A. Will o´ the wisp: CCN4 as a novel molecular target in osteoarthritis. J Cell Commun Signal. 2011;5:51–2.CrossRefPubMed Leask A. Will o´ the wisp: CCN4 as a novel molecular target in osteoarthritis. J Cell Commun Signal. 2011;5:51–2.CrossRefPubMed
38.
go back to reference van den Bosch MH, Blom AB, van Lent PL, van Beuningen HM, Blaney Davidson EN, van der Kraan PM, et al. Canonical Wnt signaling skews TGF-β signaling in chodrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal. 2014;26:951–8.CrossRefPubMed van den Bosch MH, Blom AB, van Lent PL, van Beuningen HM, Blaney Davidson EN, van der Kraan PM, et al. Canonical Wnt signaling skews TGF-β signaling in chodrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal. 2014;26:951–8.CrossRefPubMed
39.
go back to reference Urano T, Narusawa K, Hosoi T, Ouchi Y, Nakamura T, Inoue S. Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women. J Bone Miner Metab. 2007;25:253–8.CrossRefPubMed Urano T, Narusawa K, Hosoi T, Ouchi Y, Nakamura T, Inoue S. Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women. J Bone Miner Metab. 2007;25:253–8.CrossRefPubMed
40.
go back to reference Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039–49.CrossRefPubMed Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039–49.CrossRefPubMed
42.
go back to reference Mishra R, Singh A, Chandra V, Negi M, Tripathy BC, Prakash J, et al. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol Int. 2012;32:2377–82.CrossRefPubMed Mishra R, Singh A, Chandra V, Negi M, Tripathy BC, Prakash J, et al. A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol Int. 2012;32:2377–82.CrossRefPubMed
43.
go back to reference Hong JM, Kim TH, Chae SC, Koo KH, Lee YJ, Park EK, et al. Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population. Osteoarthritis Cartilage. 2007;15:688–94.CrossRefPubMed Hong JM, Kim TH, Chae SC, Koo KH, Lee YJ, Park EK, et al. Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population. Osteoarthritis Cartilage. 2007;15:688–94.CrossRefPubMed
44.
go back to reference French DM, Kaul RJ, D’Souza AL, Crowley CW, Bao M, Frantz GD, et al. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol. 2004;165:855–67.CrossRefPubMedPubMedCentral French DM, Kaul RJ, D’Souza AL, Crowley CW, Bao M, Frantz GD, et al. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol. 2004;165:855–67.CrossRefPubMedPubMedCentral
Metadata
Title
Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study
Authors
Javier Fernández-Torres
Cristina Hernández-Díaz
Rolando Espinosa-Morales
Javier Camacho-Galindo
Norma del Carmen Galindo-Sevilla
Ámbar López-Macay
Yessica Zamudio-Cuevas
Karina Martínez-Flores
Mónica Guadalupe Santamaría-Olmedo
Carlos Pineda
Julio Granados
Gabriela Angélica Martínez-Nava
Marwin Gutiérrez
Alberto G. López-Reyes
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2015
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-015-0678-z

Other articles of this Issue 1/2015

BMC Musculoskeletal Disorders 1/2015 Go to the issue